http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4766126-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
filingDate 1987-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1988-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26d586abead4456f31a5a5cf3b6e453b
publicationDate 1988-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4766126-A
titleOfInvention Process for treatment of nephritis with imidazoquinazolines
abstract An agent for treatment and prevention of nephritis comprising at least one imidazoquinazoline compound represented by formula <IMAGE> wherein R1 represents a dialkylamino group having 1 to 6 carbon atoms in each alkyl moiety, or an unsubstituted or substituted cyclic amino group; and R2 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, or an alkoxy group having 1 to 6 carbon atoms, or a salt thereof as an active ingredient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5707621-A
priorityDate 1986-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4596806-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4610987-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0133234-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0129258-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128625518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10198308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226870843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22054459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235175326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235175325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67932889
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45078362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226508514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135418419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128622565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409332

Total number of triples: 45.